Papers Is travel prophylaxis worth while? Economic appraisal of prophylactic measures against malaria, hepatitis A, and typhoid in travellers BMJ 1994; 309 doi: https://doi.org/10.1136/bmj.309.6959.918 (Published 08 October 1994) Cite this as: BMJ 1994;309:918 Article Related content Metrics Responses Peer review Related articles No related articles found. See more Bird flu: Person with rare strain in US sparks alarm about cow transmission BMJ April 04, 2024, 385 q797; DOI: https://doi.org/10.1136/bmj.q797 Antibiotic costs rise 1100% as big pharma exits Nigeria BMJ March 01, 2024, 384 q328; DOI: https://doi.org/10.1136/bmj.q328 Measles: 500 cases are confirmed in England as clusters appear around the country BMJ February 15, 2024, 384 q417; DOI: https://doi.org/10.1136/bmj.q417 Alaskapox: First human death from zoonotic virus is announced BMJ February 15, 2024, 384 q415; DOI: https://doi.org/10.1136/bmj.q415 Diphtheria: WHO publishes first ever guidance following outbreaks BMJ February 14, 2024, 384 q407; DOI: https://doi.org/10.1136/bmj.q407 Cited by... La protection des voyageurs canadiens : mieux vaut prevenir que guerirFulltext PDF Protecting Canadian travellers: Prevention is better than cureFulltext PDF Improving the evidence base for pre-travel advice: the importance of surveillance of travel-associated infectionFulltext PDF Protecting travellers from hepatitis AFulltext PDF Typhoid fever vaccines: a meta-analysis of studies on efficacy and toxicityFulltext PDF Abstract Vaccinations for travellersFulltext PDF Abstract Risk for British travellers of acquiring hepatitis AFulltext PDF Abstract Assumptions were confusingFulltext PDF Abstract Travel prophylaxisFulltext PDF Abstract Journals should develop guidelines for economic evaluationsFulltext PDF Abstract Vaccination against hepatitis A for travellersFulltext PDF Abstract All relevant costs and consequences should be measuredFulltext PDF Abstract